Fate Therapeutics
FATE
$3.87
Share price
-10.00%
Change (1 day)
-38.96%
Change (1 year)
Categories
Operating Margin for Fate Therapeutics (FATE)
Operating Margin as of April 2024 (TTM): -191.80%
According to Fate Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -191.80%. At the end of 2021 the company had an Operating Margin of -379.89%.
Operating Margin history for Fate Therapeutics from 2013 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -379.89% | -31.13% |
| 2020 | -551.59% | -38.89% |
| 2019 | -902.59% | -34.08% |
| 2018 | -1,369.24% | 34.87% |
| 2017 | -1,015.20% | 40.42% |
| 2016 | -722.97% | -36.72% |
| 2015 | -1,142.41% | |
| 2013 | -2,069.82% | 301.86% |
| 2012 | -515.06% | -54.69% |
| 2011 | -1,136.75% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Becton Dickinson BDX | 9.46% | -104.93% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | -88.19% | -54.02% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | -84.20% | -56.10% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | 14.36% | -107.49% | 🇺🇸 USA |
 Avidity Biosciences RNA | -1,886.32% | 883.48% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.